PCSK9 is not secreted from mature differentiated intestinal cells
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes lysosomal degradation of the LDL receptor and is a key regulator of cholesterol metabolism. After the liver, the small intestine is the second organ that highly expresses PCSK9. However, the small intestine's ability to secrete PCSK...
Main Authors: | Moreau François, Aurélie Thédrez, Damien Garçon, Audrey Ayer, Thibaud Sotin, Wieneke Dijk, Claire Blanchard, Gilliane Chadeuf, Lucie Arnaud, Mikael Croyal, Laurianne Van Landeghem, Melissa Touvron, Xavier Prieur, Anna Roubtsova, Nabil Seidah, Annik Prat, Bertrand Cariou, Cedric Le May |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752100078X |
Similar Items
-
Corrigendum: PCSK9 is not secreted from mature differentiated intestinal cells
by: François Moreau, et al.
Published: (2022-04-01) -
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity
by: Malak Alannan, et al.
Published: (2022-12-01) -
Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis
by: Malak Alannan, et al.
Published: (2022-12-01) -
PCSK9: A emerging participant in heart failure
by: Qian Xu, et al.
Published: (2023-02-01) -
Impact of PCSK9 on CTRP9-Induced Metabolic Effects in Adult Rat Cardiomyocytes
by: Susanne Rohrbach, et al.
Published: (2021-02-01)